Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

Abdominal aortic aneurysms (AAA) are characterized by disruption and degradation of the elastic media, yet the elastolytic proteinases involved and their cellular sources are undefined. We examined if 92-kD gelatinase, an elastolytic matrix metalloproteinase, participates in the pathobiology of AAA. Gelatin zymography of conditioned medium from normal, atheroocclusive disease (AOD), or AAA tissues in organ culture showed that all tissues produced 72-kD gelatinase. AOD and AAA cultures also secreted 92-kD gelatinase, but significantly more enzyme was released from AAA tissues. ELISA confirmed that AAA tissues released approximately 2-fold more 92-kD gelatinase than AOD tissue and approximately 10-fold more than normal aorta. Phorbol ester induced a 5.3-fold increase in 92-kD gelatinase secretion by normal aorta and AOD and an 11.5-fold increase by AAA. By immunohistochemistry, 92-kD gelatinase was not detected in normal aorta and was only occasionally seen within the neointimal lesions of AOD tissue. In all AAA specimens, however, 92-kD gelatinase was readily localized to numerous macrophages in the media and at the adventitial-medial junction. The expression of 92-kD gelatinase mRNA by aneurysm-infiltrating macrophages was confirmed by in situ hybridization. These results demonstrate that diseased aortic tissues secrete greater amounts of gelatinolytic activity than normal aorta primarily due to increased production of 92-kD gelatinase. In addition, the localization of 92-kD gelatinase to macrophages in the damaged wall of aneurysmal aortas suggests that chronic release of this elastolytic metalloproteinase contributes to extracellular matrix degradation in AAA.

[1]  G. Sicard,et al.  Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. , 1994, Journal of vascular surgery.

[2]  W. Parks,et al.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. , 1994, The Journal of clinical investigation.

[3]  J. Olerud,et al.  Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. , 1993, The Journal of clinical investigation.

[4]  T. Ley,et al.  Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. , 1993, The Journal of biological chemistry.

[5]  S. Katsuda,et al.  An elastinolytic enzyme detected in the culture medium of human arterial smooth muscle cells , 1993, Cell biology international.

[6]  G. Tromp,et al.  Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. , 1993, The Journal of clinical investigation.

[7]  W. Pearce,et al.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. , 1993, The American journal of pathology.

[8]  W. Parks,et al.  92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. , 1993, The American journal of pathology.

[9]  J. Hoidal,et al.  Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. , 1993, The Journal of clinical investigation.

[10]  W. Parks,et al.  Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum. , 1993, The Journal of investigative dermatology.

[11]  W. Pearce,et al.  Interleukin-1β and tumor necrosis factor-α release in normal and diseased human infrarenal aortas * ** * , 1992 .

[12]  W. Parks,et al.  Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. , 1992, The Journal of clinical investigation.

[13]  C. Brophy,et al.  Characterization of an elastase from aneurysmal aorta which degrades intact aortic elastin , 1992, Annals of vascular surgery.

[14]  J. Cohen,et al.  Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms. , 1992, Annals of surgery.

[15]  J. Dayer,et al.  Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. , 1992, The Journal of clinical investigation.

[16]  J Ochsner,et al.  Recommended indications for operative treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the Society for Vascular Surgery and the North American Chapter of the International Society for Cardiovascular Surgery. , 1992, Journal of vascular surgery.

[17]  E. Kieffer,et al.  Pathogenesis of acquired aneurysms of the abdominal aorta , 1992, Annals of vascular surgery.

[18]  A. Strongin,et al.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.

[19]  R. Mecham,et al.  Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. , 1992, The American journal of pathology.

[20]  D. Reed,et al.  Are Aortic Aneurysms Caused by Atherosclerosis? , 1992, Circulation.

[21]  U. Thorgeirsson,et al.  Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. , 1992, Invasion & metastasis.

[22]  G. Murphy,et al.  Physiological mechanisms for metalloproteinase activation. , 1992, Matrix (Stuttgart, Germany). Supplement.

[23]  Z. Werb,et al.  Fibronectin fragments, but not intact fibronectin, signalling through the fibronectin receptor induce metalloproteinase gene expression in fibroblasts. , 1992, Matrix (Stuttgart, Germany). Supplement.

[24]  R. Chisholm,et al.  Aneurysm or occlusive disease--factors determining the clinical course of atherosclerosis of the infrarenal aorta. , 1991, Surgery.

[25]  R. Stoney,et al.  Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  J. Powell,et al.  Metalloproteinases in degenerative aortic disease. , 1991, Clinical science.

[27]  M. Cockett,et al.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). , 1991, The Biochemical journal.

[28]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  C. Brophy,et al.  The role of inflammation in nonspecific abdominal aortic aneurysm disease , 1991, Annals of vascular surgery.

[30]  J A Pierce,et al.  Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. , 1991, The Journal of clinical investigation.

[31]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[32]  S. Shapiro,et al.  Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. , 1991, Journal of immunology.

[33]  B. Sumpio,et al.  Electrophoretic characterization of protease expression in aneurysmal aorta : report of a unique 80kDa elastolytic activity , 1991 .

[34]  D. Steed,et al.  On the inheritance of abdominal aortic aneurysm. , 1991, American journal of human genetics.

[35]  W. Pearce,et al.  Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. , 1990, The American journal of pathology.

[36]  A. Eisen,et al.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. , 1990, The Journal of clinical investigation.

[37]  H. Birkedal‐Hansen,et al.  The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Matrisian,et al.  Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.

[39]  J. Powell,et al.  Genetic variation on chromosome 16 is associated with abdominal aortic aneurysm. , 1990, Clinical science.

[40]  J. S. Yao,et al.  Collagen types and matrix protein content in human abdominal aortic aneurysms. , 1989, Journal of vascular surgery.

[41]  J. Powell,et al.  Cellular, enzymatic, and genetic factors in the pathogenesis of abdominal aortic aneurysms. , 1989, Journal of vascular surgery.

[42]  J. Cohen,et al.  Elastin metabolism of the infrarenal aorta. , 1988, Journal of vascular surgery.

[43]  P. Herrlich,et al.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region , 1987, Molecular and cellular biology.

[44]  J. Powell,et al.  Elastin degradation in abdominal aortic aneurysms. , 1987, Atherosclerosis.

[45]  P. Herrlich,et al.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region , 1987, Molecular and cellular biology.

[46]  R. Senior,et al.  12-o-Tetradecanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases. High levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G. , 1986, The Journal of clinical investigation.

[47]  J. Seyer,et al.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. , 1985, The Journal of biological chemistry.

[48]  R. Mecham,et al.  Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes , 1984, The Journal of cell biology.

[49]  H. Welgus,et al.  Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. , 1983, The Journal of biological chemistry.

[50]  H. Stansel,et al.  Differences in results for aneurysm vs occlusive disease after bifurcation grafts: results of 100 elective grafts. , 1980, Archives of surgery.

[51]  R. Mecham,et al.  Chemotactic activity of elastin-derived peptides. , 1980, The Journal of clinical investigation.

[52]  M. Lefevre,et al.  Aorta elastin turnover in normal and hypercholesterolemic Japanese quail. , 1980, Biochimica et biophysica acta.